Erich Wolf

This inventor holds 10 USPTO granted patents. Top assignees: Chimicasa Gmbh, Farco-Pharma Gesellschaft MIT Beschrankter Haftung Pharmazeutische, Farco-Pharma Gmbh. Active years: 1978-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erich Wolf. Retrieved from https://idiyas.com/inventor/erich-wolf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 93(Granted Patents)

Location History:

Overath, Marienlinden, DE (1978)
Marialinden, DE (1979)
Overath, DE (1983 - 1998)

Company Filing History:

Farco-Pharma Gesellschaft MIT Beschrankter Haftung Pharmazeutische

Years Active: 1978-1998

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5842326 - Method for fabricating a sterile ready-pack and a container for such a (1998-12-01),

2. 4696297 - Process for collecting fragments which are obtained on shattering stones (1987-09-29),

3. 4595593 - Preparation for deactivating viruses and process for producing same (1986-06-17),

4. 4592910 - Preparation for deactivating viruses and process for producing same (1986-06-03),

5. 4495213 - Water-soluble sweetening tablet (1985-01-22),

6. 4486455 - Water-soluble sweetening tablets (1984-12-04),

7. 4409245 - Protection of microorganisms against bacteriophage virus attacks (1983-10-11),

8. 4402950 - Process and preparation for deactivating viruses (1983-09-06),

9. 4158006 - Refining saccharin sodium (1979-06-12),

10. 4119730 - Treating muscle spasms (1978-10-10),

Title: The Innovative Journey of Erich Wolf

Introduction

Erich Wolf, an accomplished inventor based in Overath, Germany, holds a remarkable portfolio of ten patents. His contributions to the field of medical technology and pharmaceutical processing have made a significant impact on both industries. Wolf's innovative spirit is evident in his latest inventions, which showcase his ability to address complex problems through creative solutions.

Latest Patents

Among his most recent patents, Erich Wolf has developed a "Method for Fabricating a Sterile Ready-Pack" and a "Process for Collecting Fragments Obtained on Shattering Stones." His process introduces a gelatin solution into body cavities of living humans or animals, which remains fluid at body temperature. When shattering stones, the gelatin solution hardens upon rinsing with a cooling fluid, effectively collecting fragments for medical procedures. This innovation emphasizes his dedication to enhancing patient safety and procedural efficiency in medical practices.

Career Highlights

Throughout his career, Erich Wolf has worked with esteemed companies such as Chimicasa GmbH and Farco-Pharma Gesellschaft mit beschränkter Haftung Pharmazeutische. His experiences in these organizations have allowed him to refine his expertise in pharmaceutical innovations and medical devices, paving the way for his successful patent portfolio.

Collaborations

Wolf's professional network includes notable colleagues such as Rolf Deininger and Andreas Lembke. This collaboration has undoubtedly fostered a rich exchange of ideas and knowledge, further enhancing his innovative capabilities and the development of groundbreaking solutions.

Conclusion

Erich Wolf embodies the spirit of innovation through his impressive contributions in the field of medical technology. With a robust collection of patents and collaboration with leading companies and colleagues, he continues to push the boundaries of what is possible, ensuring improved outcomes in medical treatments and patient care. His work serves as an inspiration to aspiring inventors and established professionals alike in the pursuit of innovative solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]